Secretory Phospholipase A2-IIA and Cardiovascular Disease (original) (raw)

Lipoprotein-Associated Phospholipase A2 and Cardiovascular Risk: State of the Evidence and Future Directions

Arteriosclerosis, Thrombosis, and Vascular Biology, 2006

Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients

Teresa M Seccia

PLOS ONE, 2012

View PDFchevron_right

Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein

marita kaniawati

International Journal of Angiology, 2013

View PDFchevron_right

Advantages of the lipoprotein-associated phospholipase A2 activity assay

Leslie Donato

Clinical Biochemistry, 2016

View PDFchevron_right

Lipoprotein-associated phospholipase A2 activity improves risk discrimination of incident coronary heart disease among women

D. Bonnefont-Rousselot

American Heart Journal, 2011

View PDFchevron_right

Expression of secretory group II phospholipase A2 by CD1a positive cells in human atherosclerotic plaques

Dinh Minh Tran

Atherosclerosis, 1996

View PDFchevron_right

Systemic Antiphospholipid Syndrome and Atherosclerosis

Gabriela Nicolle Sorto Medina

Clinical Reviews in Allergy & Immunology, 2007

View PDFchevron_right

Protease Activated Receptor-2 Contributes to Heart Failure

Silvio Antoniak

PLoS ONE, 2013

View PDFchevron_right

Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study

Andrew Nicolaides

Journal of the American College of Cardiology, 2013

View PDFchevron_right

Lipoprotein-associated phospholipase A 2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population

Natalie Khuseyinova

Acc Current Journal Review, 2005

View PDFchevron_right

Apo B100-containing lipoproteins are secreted by the heart

Murielle Veniant

Journal of Clinical Investigation, 1998

View PDFchevron_right

Atherosclerosis

Adel Allam

Global Heart, 2014

View PDFchevron_right

Secretory Phospholipase A 2 Hydrolysis of Phospholipid Analogues Is Dependent on Water Accessibility to the Active Site

Günther Peters

Journal of the American Chemical Society, 2007

View PDFchevron_right

Syndrome catastrophique des antiphospholipides : les enseignements d’un cas difficile

S. Hamaz

La Revue de Médecine Interne, 2017

View PDFchevron_right

Clinical course of high‐risk patients diagnosed with antiphospholipid syndrome

Francesco Marongiu

Journal of Thrombosis and Haemostasis, 2010

View PDFchevron_right

Lipoproteins Containing Apolipoprotein B-100 Are Secreted by the Heart

Murielle Veniant

Trends in Cardiovascular Medicine, 1999

View PDFchevron_right

Find the Essence through the Phenomena: Cardiovascular Diseases and Biomarkers

Ospan Mynbaev

Disease Markers, 2018

View PDFchevron_right

Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes

Michel Lagarde

FEBS Letters, 1981

View PDFchevron_right

Secretory Phospholipase A2, Group IIA Is a Novel Serum Amyloid A Target Gene: ACTIVATION OF SMOOTH MUSCLE CELL EXPRESSION BY AN INTERLEUKIN-1 RECEPTOR-INDEPENDENT MECHANISM

Celeste Rich

Journal of Biological Chemistry, 2009

View PDFchevron_right

Calmodulin Is a Nonessential Activator of Secretory Phospholipase A2

Igor Križaj

Biochemistry, 2009

View PDFchevron_right

The Global Burden of Cardiovascular Diseases and Risk Factors

Arash Sarveazad

Journal of the American College of Cardiology, 2019

View PDFchevron_right

The Cardiometabolic Syndrome and Cardiovascular Disease

Linda Peterson

Journal of the CardioMetabolic Syndrome, 2006

View PDFchevron_right

An Initial Characterization of the Serum Phosphoproteome

Lance Liotta

Journal of Proteome Research, 2009

View PDFchevron_right

Original Reports: Cardiovascular Disease and Risk Factors

madiha khan

2012

View PDFchevron_right

Lupus Anticoagulant, Antiphospholipid Syndrome and Cardiac Surgery

Bruce Cartwright

Anaesthesia and Intensive Care, 2010

View PDFchevron_right

Expression and Secretion of Human Apolipoprotein AI In the Heart

Nadine Baroukh

FEBS letters, 2004

View PDFchevron_right

Ausência de anticorpos antilipoproteína lipase na doença de Behçet

Célio Gonçalves

Revista Brasileira de Reumatologia, 2009

View PDFchevron_right

Cyclooxygenase-2 Inhibition and Cardiovascular Events

Carl Pepine

Circulation, 2002

View PDFchevron_right

Circulating Secretory Phospholipase A2 Activity and Risk of Incident Coronary Events in Healthy Men and Women The EPIC-NORFOLK Study

Alain Tedgui

2000

View PDFchevron_right

Secretory Phospholipase A2-IIA and Cardiovascular Disease (original) (raw)

Related papers